Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net earnings	$ 107,544	$ 129,470
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	128,909	123,667
Stock-based compensation expense	12,129	12,303
Change in estimated sales allowances	(67,182)	59,865
Deferred income tax benefit	(31,488)	(5,250)
Other non-cash items	45,163	57,515
Litigation settlements, net	1,790	2,173
Changes in operating assets and liabilities:
Accounts receivable	76,690	(155,085)
Inventories	(118,925)	(70,095)
Trade accounts payable	5,875	(33,077)
Income taxes	23,115	(48,562)
Deferred revenue	(134)	(7,043)
Other operating assets and liabilities, net	(95,925)	(172,953)
Net cash provided by (used in) operating activities	87,561	(107,072)
Cash flows from investing activities:
Capital expenditures	(53,075)	(35,745)
Change in restricted cash	(53,093)	44
Cash paid for acquisitions, net	(32,100)	0
Purchase of marketable securities	(2,538)	(2,660)
Proceeds from sale of marketable securities	2,839	2,562
Other items, net	(4,294)	(72,419)
Net cash used in investing activities	(142,261)	(108,218)
Cash flows from financing activities:
Payment of financing fees	(4,983)	(1,248)
Purchase of common stock	(500,000)	0
Change in short-term borrowings, net	185,073	311,053
Proceeds from issuance of long-term debt	525,000	435,000
Payment of long-term debt	(239,442)	(673,806)
Proceeds from exercise of stock options	28,060	17,182
Other items, net	12,891	3,746
Net cash provided by financing activities	6,599	91,927
Effect on cash of changes in exchange rates	(7,447)	6,345
Net decrease in cash and cash equivalents	(55,548)	(117,018)
Cash and cash equivalents — beginning of period	349,969	375,056
Cash and cash equivalents — end of period	$ 294,421	$ 258,038